Home » Drug Information » Recently Approved Drugs » 2002
Medical Areas: Immunology/Infectious Diseases | Pediatrics/Neonatology
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Aventis Pasteur
Approval Status: Approved September 2002
Treatment Area: Influenza immunization in infants
The preservative-free formulation of the Fluzone Influenza Virus
Vaccine was approved in September 2002 to immunize high-risk and
normal infants, aged six months to 35 months.
Fluzone is also available in its non-preservative-free
formulation for pediatric and adult patients.
For further information about Fluzone, visit the Aventis Pasteur
vaccine product web site at www.vaccineshoppe.com.
